MANCHESTER, U.K. — Pill Connect, formerly known as Elucid mHealth, has elected Chris Hall chairman of the company. Pill Connect is a world leader in medicine adherence monitoring and data capture on patient compliance. This follows the recent successful funding raise involving the investment serial entrepreneur Jonathan Milner, Catapult Ventures and Shallcross Partners.
Hall has extensive commercial and operational management experience in the global pharmaceutical devices and drug delivery systems market place. He is currently non-executive chairman of Nanopharm Ltd. and a non-executive director of Silicon Valley based Kali Care. He has held senior management positions at a number of healthcare companies including Aptar and Bespak Respiratory.
CEO of Pill Connect James Burnstone Commented “We are delighted that Chris has agreed to become chairman of our company. His knowledge of the medtech world and medication adherence marketplace will enable us to move forward with our proven technology into the commercial phase of development.”
Pill Connect has developed a smart pill dispensing solution which will allow both trial investigators and doctors to effectively monitor medication adherence in real time, either in clinical trials or in the community. Pill Connect is in discussions with several top tier Pharmas, CROs, and CMOs all of whom all keen to find effective ways to monitor and improve patient adherence through the accurate collection of patient behaviour data. According to figures from the OECD poor medication adherence contributes to nearly 200,000 premature deaths in Europe every year.